Navigation Links
Parente Randolph Secures Access to New Corporate Headquarters With BIO-key(R) Biometric Identification
Date:9/30/2008

Financial Services Provider Deploys Biometric Access Control Solution,

Eliminating Need for PINs or ID Cards

WALL, N.J., Sept. 30 /PRNewswire-FirstCall/ -- BIO-key International Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety solutions and finger-based biometric identification, announced today that Parente Randolph ("Parente"), a leading accounting and consultant firm, has deployed BIO-key's biometric identity solution to secure their new headquarters.

Parente, headquartered in Philadelphia, is one of the largest accounting and consulting firms in the United States and provides a full array of financial services to their clients. In order to provide a higher level of security for their new headquarters, Parente's management team installed an access control system manufactured by BIO-key's partner, NextGenID Inc. This access control system employs BIO-key's patented and award winning biometric matching software to identify individuals before granting access to the facility. In order to enter Parente's offices at One Liberty Place in Philadelphia, employees and registered visitors simply place their finger on a conveniently located reader to gain access. Consequently, employees and visitors no longer need to carry keys or ID cards and are not burdened with having to remember PINs.

Bob Ciaruffoli, Chairman and CEO of Parente stated, "As our corporate mission states, we have an uncompromising dedication to quality and excellence in everything we undertake. After evaluating multiple options to secure our new headquarters, choosing BIO-key's fingerprint biometric access solution, which provides superior accuracy and convenience was a natural choice."

Mike DePasquale, BIO-key's President and CEO added, "Our biometric physical and logical access solutions provide superior security without the need to carry access control cards or keys which can be reproduced, lost or stolen. Our more secure and conve
'/>"/>

SOURCE BIO-key International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Clear(R) Secures $44.4 Million in Venture Funding
2. Death protein research secures funding for UCF scientists
3. UT Southwestern secures $5 million NIH grant for lupus research
4. New study finds biodiversity conservation secures ecosystem services for people
5. Life-saving clean water project secures $13M from Bill & Melinda Gates Foundation
6. St. Jude study gives new insights into how cells accessorize their proteins
7. Cuellars Safe and Lock Announces Strategic Alliance with Absolute Access and Security
8. Open access to large-scale drug discovery data
9. New chlorine-tolerant, desalination membrane hopes to boost access to clean water
10. Excellence in open access research celebrated at BioMed Central awards dinner
11. Open-access tropical conservation journal launches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Census Bureau, Latinos are the largest minority group in ... Approximately one-third of Latinos are obese and are 1.2 ... Whites. , NYU College of Nursing student researcher ... identify the factors that contribute to this problem by ... on food patterns in Latina women recently published in ...
(Date:7/31/2014)... follow-up study (HPV-023; NCT00518336) shows the sustained ... papilloma virus (HPV) vaccine Cervarix. Women vaccinated ... for more than nine years, and vaccine ... This is the longest follow-up report for ... for the full paper. , ...
(Date:7/31/2014)... from Spain, France, and the U.S. has discovered ... oldest definitive member of the tribe Omaliini that ... and description were made possible through the use ... which allows the detailed study of otherwise invisible ... described in the journal Annals of the ...
Breaking Biology News(10 mins):NYU research looks to combat US Latina immigrant obesity 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 3
... Research has awarded a five-year, $7.5 million grant to a ... project is to study birds, insects and bats in order ... fly in unpredictable conditions such as zooming through dense ... to fly in open spaces or in very controlled environments," ...
... Spanish . U.S. Department of Agriculture ... first time that several species of Aspergillus niger ... and peanuts as endophytes. The researchers also showed that, ... a molecular procedure they developed, USDA Agricultural Research Service ...
... The National Institute of General Medical Sciences (NIGMS) has ... Yeshiva University a five-year, $30 million grant to study ... proteins. "Determining the structures of proteins is the ... processes as well as in disease pathways," says principal ...
Cached Biology News:UW leading $7.5 million study of animal flight and aerial vehicles 2Black aspergilli species responsible for infecting corn identified 2Einstein receives $30 million to study protein form and function 2Einstein receives $30 million to study protein form and function 3Einstein receives $30 million to study protein form and function 4
(Date:7/31/2014)... -- Chemists at Indiana University Bloomington have described ... fashion, a development with potential value for the ... transistors and photovoltaic cells. , Their paper, "Anion-Induced ... Solids and 2D Self-Assembled Crystals," has been published ... of the Royal Society of Chemistry. It is ...
(Date:7/31/2014)... Rogne Bioscience, a privately-held biotechnology company based ... has acquired a licence to anti-inflammatory peptides from Isis ... anti-inflammatory activity of the peptides was discovered by Professor ... Sir William Dunn School of Pathology. ... million in seed financing, is developing a first-in-class, topical ...
(Date:7/31/2014)... July 31, 2014 According to ... "Electrodes for Medical Devices Market (Diagnostic Electrodes - ECG, ... - TENS, Pacemakers, Defibrillators, Electrosurgical and Other Electrodes) - ... 2013 - 2019," the global electrodes market for medical ... and is estimated to reach a market worth USD ...
(Date:7/31/2014)... July 31, 2014 Senomyx , ... company using proprietary taste science technologies to discover, ... food, beverage, and ingredient supply industries, today reported ... Company ended the second quarter with $33.6 million ... "During the past quarter Senomyx achieved another ...
Breaking Biology Technology:Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 3Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 2Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 3Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 4Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 5Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 6SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 14SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 15SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 16
... Seamless Performance Between GeneChip Scanner 3000 and the ... , ... Instrument System is the most advanced microarray analysis platform available and ... processes have enabled Affymetrix to produce expression probe arrays with greater consistency ...
... , Gang Li a , Savvas Damaskinos a ... a Biomedical Photometrics Inc., A12-550 Parkside ... b Dept. of Biology, Wilfrid Laurier University, 75 University Ave. ... , ABSTRACT , ...
... , L.Pereira, 1 M.Woodruff, 1 P.Deland, 2 ... , ... CA,USA , 3 Astra Zeneca R&D, Charnwood,UK , ... performance of various diode array detectors in the analysis of trace related substances of a ...
Cached Biology Technology:The New Affymetrix GeneChip Scanner 3000 2The New Affymetrix GeneChip Scanner 3000 3The New Affymetrix GeneChip Scanner 3000 4The New Affymetrix GeneChip Scanner 3000 5The New Affymetrix GeneChip Scanner 3000 6The New Affymetrix GeneChip Scanner 3000 7The New Affymetrix GeneChip Scanner 3000 8The New Affymetrix GeneChip Scanner 3000 9The New Affymetrix GeneChip Scanner 3000 10The New Affymetrix GeneChip Scanner 3000 11The New Affymetrix GeneChip Scanner 3000 12The New Affymetrix GeneChip Scanner 3000 13The New Affymetrix GeneChip Scanner 3000 14The New Affymetrix GeneChip Scanner 3000 15A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 2A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 3A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 4A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 5A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 6A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 7A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 8A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 9A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 10A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 11A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 12A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 13A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 14A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 15A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 16A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 17A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 18A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 19A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 20A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 21A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 22
... The Light Diagnostics Universal Amplicon ... for use in the qualitative ... generated by in vitro ... use only; not to be ...
{3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide}. ,250 ug/ml Propidium Iodide (PI) in PBS....
... complete ready-to-use reagents for the isolation of ... formulated for the isolation of genomic DNA ... formulated for the isolation of genomic DNA ... Reagents can be used for restriction endonuclease ...
Concentration: 1mg/ml. Antigen: Propidium Iodide ...
Biology Products: